Agenda

Our esteemed Advisory Board - comprising leaders from Biotech, Pharma, VC and Academia - is currently shaping the Longevity Biotech 2025 program.

Expect a focused agenda exploring the most promising therapeutic approaches, translational challenges, and commercial pathways in the field of longevity.

Want to be the first to receive agenda updates?

Submit the form to stay informed as speakers and sessions are announced